AstraZeneca may run additional trial

The new trial would be run instead of adding an arm to an ongoing US trial and would evaluate a lower dosage that performed better than a full amount in AstraZeneca’s studies, according to a Bloomberg report

from Hindustan Times - india https://ift.tt/33l3GE4
via IFTTT